EXONOX Trademark

Trademark Overview


On Monday, June 15, 2020, a trademark application was filed for EXONOX with the United States Patent and Trademark Office. The USPTO has given the EXONOX trademark a serial number of 90002221. The federal status of this trademark filing is REGISTERED as of Tuesday, August 31, 2021. This trademark is owned by EXOPHARM BIOSCIENCES, INC.. The EXONOX trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic biomarker reagents for medical purposes; Diagnostic test reagent, namely, medical diagnostic reagents and assays for testing cancers, metabolic diseases, cardiorenal diseases, neurodegenerative diseases; Chemical reagent for medical purposes; Reagent paper for medical purposes; Biological preparations for medical purposes, namely, medical diagnostic reagents and assays for testing cancers, metabolic diseases, cardiorenal diseases, neurodegenerative diseases; Medicines for human purposes, namely, medicines for treating cancers, metabolic diseases, cardiorenal diseases, neurodegenerative diseases; Chemico-pharmaceutical preparations, namely, medical diagnostic reagents and assays for testing cancers, metabolic diseases, cardiorenal diseases, neurodegenerative diseases
exonox

General Information


Serial Number90002221
Word MarkEXONOX
Filing DateMonday, June 15, 2020
Status700 - REGISTERED
Status DateTuesday, August 31, 2021
Registration Number6466487
Registration DateTuesday, August 31, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 15, 2021

Trademark Statements


Goods and ServicesDiagnostic biomarker reagents for medical purposes; Diagnostic test reagent, namely, medical diagnostic reagents and assays for testing cancers, metabolic diseases, cardiorenal diseases, neurodegenerative diseases; Chemical reagent for medical purposes; Reagent paper for medical purposes; Biological preparations for medical purposes, namely, medical diagnostic reagents and assays for testing cancers, metabolic diseases, cardiorenal diseases, neurodegenerative diseases; Medicines for human purposes, namely, medicines for treating cancers, metabolic diseases, cardiorenal diseases, neurodegenerative diseases; Chemico-pharmaceutical preparations, namely, medical diagnostic reagents and assays for testing cancers, metabolic diseases, cardiorenal diseases, neurodegenerative diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 13, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEXONOX BIOSCIENCES, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTAIPEI CITY 105 R.O.C.
TW

Party NameEXONOX BIOSCIENCES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTAIPEI CITY 105 R.O.C.
TW

Party NameEXONOX BIOSCIENCES, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressTAIPEI CITY 105 R.O.C.
TW

Party NameEXOPHARM BIOSCIENCES, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTaipei City 105 R.O.C.
TW

Trademark Events


Event DateEvent Description
Tuesday, August 31, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, June 15, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 15, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 21, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 7, 2021ASSIGNED TO LIE
Wednesday, February 3, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, January 7, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 22, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 22, 2020NON-FINAL ACTION E-MAILED
Tuesday, September 22, 2020NON-FINAL ACTION WRITTEN
Thursday, September 17, 2020ASSIGNED TO EXAMINER
Thursday, August 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 27, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 27, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 27, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 18, 2020NEW APPLICATION ENTERED IN TRAM